Reporting with the tools provided by MODA-EM has been the key to enable us to fully maximize the paperless solution
Las Vegas, NV (PRWEB) April 16, 2009
The Parenteral Drug Association (PDA) is hosting their annual meeting in Las Vegas, NV on April 20-24, 2009 at Red Rock Casino and Resort. During this event, MODA Technology Partners--a software company that specializes in automating environmental monitoring, product and utility testing--and its customers will be demonstrating the value of implementing a Paperless QC Micro solution.
On April 21, the following concurrent sessions will take place under the "Quality Science" track:
- 8:00 - 8:30 am: A Novel Approach to Addressing Low Level Trends and Non-Zero Results--presented by Robert Lutskus, Supervisor, QC Microbiology Laboratory Systems, ImClone Systems.
- 8:30 - 9:00 am: Improvement in QC Environmental Monitoring Processes by Implementation of a Paperless Data Capture System--presented by Tim Coleman, Senior Director, QC Testing Services, Lonza Walkersville.
"Reporting with the tools provided by MODA-EM has been the key to enable us to fully maximize the paperless solution," explains Robert Lutskus at ImClone Systems. "The wide varieties of reports allow us to trend information that previously was not reconciled easily--and, the reporting package allows for detailed and summary level reporting for all aspects of sampling, testing and other results trending."
Additionally, personal demonstrations of MODA-EM™ will be given in Booth 604. At the booth, press and attendees can have direct discussions with ImClone Systems and Lonza Walkersville.
To learn more about PDA's Annual Meeting, visit http://www.pda.org.
To attend MODA's QC Micro Webinar Series or download past presentations, visit http://www.modatp.com.
MODA provides a mobile data acquisition platform that enables quality assurance and quality control organizations to automate their regulated manufacturing processes, including pharmaceuticals and consumer products. MODA's flagship software, MODA-EM™, is a paperless solution that leverages mobile computing technology and advanced visualization tools for increased operational efficiency, improved quality, and reduced costs. For more information, visit http://www.modatp.com.
About ImClone Systems
ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company, is committed to advancing oncology care by developing and commercializing a portfolio of targeted biologic treatments designed to address the medical needs of patients with a variety of cancers. For more information, visit http://www.imclone.com.
About Lonza and Lonza Walkersville
Lonza is one of the world's leading suppliers to the pharmaceutical, healthcare and life science industries. Its products and services span its customers' needs from research to final product manufacture. Lonza is the global leader in the production and support of active pharmaceutical ingredients both chemically as well as biotechnologically. Lonza has strong capabilities in large and small molecules, peptides, amino acids and niche bioproducts which play an important role in the development of novel medicines and healthcare products. Lonza is a leader in cell-based research, endotoxin detection and cell therapy manufacturing. Lonza is also a leading provider of value chemical and biotech ingredients to the nutrition, hygiene, preservation, agro and personal care markets. Lonza Walkersville, Inc (formerly Cambrex BioScience Walkersville, Inc) manufactures products for five distinct business units; Cell Discovery, Molecular Biology, Media, Rapid Testing and Cell Therapy Contract Manufacturing. The products range from research reagents to licensed test kits to regulated parenteral products. For more information, visit http://www.lonza.com.
The Parenteral Drug Association (PDA) is the leading global provider of science, technology and regulatory information and education for the pharmaceutical and biopharmaceutical community. Founded in 1946 as a nonprofit organization, PDA is committed to developing scientifically sound, practical technical information and resources to advance science and regulation through the expertise of its more than 11,000 members worldwide. For more information, visit http://www.pda.org.
# # #